Objectives: This study aims to evaluate the red blood cell distribution width (RDW) levels of patients with nasal polyposis (NP), and investigate its value as an inflammatory parameter and possible correlation with the severity of the disease.
Nasal polyposis (NP) is a chronic inflammatory disease characterized by edematous masses originating from the mucous membrane of the nasal cavity or paranasal sinuses. [1] Nasal polyposis significantly reduces quality of life because of symptoms like nasal obstruction, nasal/postnasal dripping, hyposmia/anosmia, and headache. [2, 3] Although the exact etiology is still unknown, tissue eosinophilia is accepted to be a characteristic histological appearance. [4] Red blood cell distribution width (RDW) is calculated by dividing the standard deviation of red blood cell volume by mean corpuscular volume (MCV). [5] It has diagnostic value in differentiating anemia. Nowadays, there is growing evidence that RDW is a useful inflammatory parameter in assessing the disease severity of various chronic inflammatory diseases. [6] [7] [8] The aim of this study was to evaluate the RDW values of patients with NP, and investigate its correlation with severity of the disease.
PATIENTS AND METHODS
This study was approved by Başkent University School of Medicine Review Board (Project no: KA16/105). Informed consent was not obtained from the patients because the study was retrospective and only the anonymous data was used. Medical records of 139 patients operated on for NP were evaluated retrospectively. Nasal polyposis was defined as the presence of bilateral polyps in the middle meatus by using anterior rhinoscopy and/or endoscopic endonasal examination, and bilateral mucosal disease on paranasal computed tomography (CT). [9] Eighty patients who were operated on for nasal septum deviation with no medical history of any other inflammatory or systemic diseases were used as control group. Nasal polyposis patients who had data about hematological parameters and disease severity were included in the study. In predicting the severity of NP, number of total eosinophils in complete blood count (CBC), total serum immunoglobulin E (IgE), polyp stage, and paranasal sinus CT score parameters were used. Polyp stage was predicted as 1-3 as reported by Lildholdt et al. [10] The Lund-Mackay system [11] was used to score opacification of the paranasal sinuses. Prior to preoperative anesthesia consultation and oral steroid administration for planned endoscopic sinus surgery, complete blood count measurements were performed with a hematology analyzer (Beckman Coulter LH780; Beckman Coulter, Brea, CA, USA). The reference range for RDW was 11.6-15.5%.
Patients who presented to our clinic between January 2003 and September 2016, and for whom clinical, laboratory, and radiological information were completely retrievable were included to the study. Exclusion criteria were: history of previous operation for NP, local or systemic usage of steroid therapy during the last four weeks, anemia, malignancy, diabetes mellitus, immunosupression, and any other chronic or acute systemic inflammatory diseases. 
Statistical analysis
Statistical analysis was performed by using SPSS for Windows version 15.0 (SPSS Inc., Chicago, IL, USA). Student t test was used for the comparison of RDW values between two groups. Pearson correlation was used for correlation analysis. A value of p<0.05 was considered statistically significant.
RESULTS
The study included 139 NP patients (87 males, 52 females; mean age 46.6 years; range 22 to 87 years) and 80 septoplasty patients (control group) (59 males, 21 females; mean age 30.3 years; range 17 to 64 years). In the NP group, 44 (31.7%) patients were stage 1, 55 (39.6%) patients were stage 2, and 40 (28.8%) patients were stage 3.
Mean serum total IgE was 152.0±198.3 IU/mL, and mean number of total eosinophils was 0.4±0.2 K/µL in NP group. Table 1 shows the clinical characteristics of patients with NP.
The RDW was above normal values in 56 (40.3%) NP patients and nine (11.25%) patients in the control group. Among these patients mean RDW was 16.53±1.54%. Table 2 shows RDW characteristics in NP and control groups. Mean RDW was 15.39±1.42% in NP group. Mean RDW was 14.64±0.83% in the control group. The difference was statistically significant between two groups (p<0.001).
There were no statistically significant correlation between RDW and total IgE (p=0.58), number of total eosinophils (p=0.58), CT scores (p=0.78) (Table 3) , and polyp stage (p=0.798) ( Table 4) .
DISCUSSION
In this study, the mean RDW value significantly increased in NP patients, compared to the controls. The RDW was above normal values in 56 (40.3%) NP patients and nine (11.25%) patients in the control group. To the best of our knowledge, this is the first study showing the RDW increase in NP.
Nasal polyposis is an inflammatory disease in which tissue eosinophilia is accepted to be a characteristic histological appearance. [4, 12] Toxic inflammatory mediators secreted by activated eosinophils and other inflammatory cells cause a series of pathological processes like epithelial injury, excessive mucus secretion, increase in vascular permeability, and edema within the nasal and paranasal sinus mucosa. One of these mediators is interleukin-5 (IL-5) which is known to have a key importance in maintenance of tissue eosinophilia and reported to be increased in NP compared to healthy controls. [13] On the other hand, a variety of other cytokines like IL-6, IL-8, IL-11, IL-16 are nonspecific markers of the inflammation in these patients. [14, 15] IL-16 is a highly potent chemotactic and chemoattractant molecule for eosinophils. Lackner et al. [15] reported a local increase of IL-16 in nasal polyp tissue. However, Keseroglu et al. [16] showed that levels of IL-16 in NP patients were also significantly increased in peripheral blood and concluded that it supports the presence of a systemic eosinophil activation in NP. Based on this, it can be speculated that NP is a chronic systemic inflammation.
It has been demonstrated that a positive association exists between RDW and conventional inflammatory biomarkers. [6] Even a low grade inflammation may result in anisocytosis. [17, 18] There is growing literature about various inflammatory diseases such as psoriasis vulgaris, hepatitis B, familial Mediterranean fever, Takayasu arteritis revealing that RDW is a valuable inflammatory marker to assess disease activity in patients without anemia. [19] [20] [21] [22] Our study also revealed a significant RDW elevation in NP as in other systemic inflammatory diseases.
The waste products of tissue inflammation are reactive oxygen species (ROS) composed of free radicals, leading to oxidative stress. Nowadays, the relation of free radicals with epithelial events in nasal polyposis is under special interest. There is growing evidence revealing higher oxygen radical levels versus lower antioxidant levels in tissue and blood samples in the patients with NP. [23, 24] On the other hand, inverse effects of oxidative stress on erythrocyte homeostasis and survival is already reported. [25] Low serum antioxidant concentrations have been reported to be negatively correlated with RDW. [26] Therefore, it can be speculated that the oxidative stress or chronic hypoxemia caused by NP might be one of the reasons for increased RDW in our study group.
Although it was significantly elevated, we failed to demonstrate the value of RDW in predicting the severity of disease. Further prospective studies including surveys predicting quality of life may be planned for estimating self-perceived severity.
One of the major limitations of this study is its being retrospective. Elevated RDW is also associated with iron deficiency, folate or vitamin B12 deficiency, sickle cell-b-thalassemia, immune hemolytic anemia, cytotoxic chemotherapy, chronic liver disease, myelodysplastic syndrome. However, our study and control groups included otherwise healthy patients by history. All the patients were preoperatively evaluated by the anesthesia department and none of them had anemia on CBC, or elevated preoperative liver enzymes in laboratory tests. Moreover, in a report by Zou et al., [27] baseline RDW in patients with systemic lupus erythematous was evaluated in anemic and nonanemic patient groups. They concluded that RDW was a valuable predictor of therapeutic outcomes and the risk of disease flare irrespective of anemia status. However, for overcoming these limitations prospective studies considering all these variables are suggested.
In conclusion, although the pathophysiology of NP is still under debate, it is known to be a chronic inflammatory disease characterized by tissue eosinophilia. Red blood cell distribution width is regarded as a systemic inflammatory parameter and a positive association exists between RDW and conventional inflammatory biomarkers. This study revealed that RDW levels in NP are significantly increased compared to healthy controls. Thus, the RDW value may be a valuable predictor in reflecting the inflammatory status. Because we failed to demonstrate an association with the severity of the disease in this retrospective study, further prospective studies are needed to evaluate the exact association.
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